Literature DB >> 9412931

Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan.

Y Watanabe1, K Ozasa, A Higashi, K Hayashi, S Mizuno, M Mukai, H Inokuchi, K Miki, K Kawai.   

Abstract

We enrolled five hundred twenty-one patients with atrophic gastritis and 769 controls in a case-control study of atrophic gastritis and Helicobacter pylori infection and lifestyle factors. The participants had no history of upper gastrointestinal surgery. They were selected from 1,395 adult (35 years or older) residents of a rural town in Kyoto prefecture who participated in an annual health examination in 1987. Atrophic gastritis was diagnosed on the basis of serum pepsinogen levels: pepsinogen I levels (< or = 70 ng/ml) and pepsinogen I/pepsinogen II ratios (< or = 3.0). The presence of immunoglobulin G antibodies to H. pylori indicated H. pylori infection. At the time of the health examination, participants were interviewed about daily lifestyle habits such as use of cigarettes and alcoholic beverages and consumption of green-yellow vegetables. Unconditional logistic regression analysis indicated that H. pylori infection was associated with a significantly increased risk for atrophic gastritis for all participants (odds ratio, 8.17; 95% confidence interval, 5.63-11.84); for men (odds ratio, 10.91; 95% CI, 5.25-22.67); and for women (odds ratio, 7.28; 95% CI, 4.72-11.22). We found no statistically significant relations between lifestyle factors and atrophic gastritis.

Entities:  

Mesh:

Year:  1997        PMID: 9412931     DOI: 10.1097/00004836-199707000-00024

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Serologically Determined Gastric Mucosal Condition Is a Predictive Factor for Osteoporosis in Japanese Men.

Authors:  Shigeto Mizuno; Daisuke Matsui; Isao Watanabe; Etsuko Ozaki; Nagato Kuriyama; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2015-02-08       Impact factor: 3.199

2.  Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.

Authors: 
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.

Authors:  Jennifer M Yeh; Chin Hur; Zachary Ward; Deborah Schrag; Sue J Goldie
Journal:  Gut       Date:  2015-03-16       Impact factor: 23.059

4.  Helicobacter pylori infection and atrophic gastritis: a nested case-control study in a rural town in Japan.

Authors:  K Ozasa; J H Kurata; A Higashi; K Hayashi; H Inokuchi; K Miki; M Tada; K Kawai; Y Watanabe
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

5.  Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.

Authors:  Shuxia Qin; Xuehong Wang; Sini Li; Chongqing Tan; Xiaohui Zeng; Xia Luo; Lidan Yi; Liubao Peng; Meiyu Wu; Ye Peng; Liting Wang; Xiaomin Wan
Journal:  Pharmacoeconomics       Date:  2022-06-15       Impact factor: 4.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.